key: cord-0872486-u4y7d7de
authors: Fortunato, Allana Cristina; Pinheiro, Rafael Soares; Fernandes, Michel Ribeiro; Nacif, Lucas Souto; Arantes, Rubens Macedo; Rocha-Santos, Vinicius; Waisberg, Daniel Reis; de Martino, Rodrigo Bronze; Ducatti, Liliana; Haddad, Luciana Bertocco; Song, Alice Tung; Abdala, Edson; Andraus, Wellington; Carneiro-D´Albuquerque, Luiz Augusto
title: COVID-19 PANDEMIC IMPACT ON LIVER DONATION IN THE LARGEST BRAZILLIAN TRANSPLANTATION CENTER
date: 2022-04-21
journal: Transplant Proc
DOI: 10.1016/j.transproceed.2022.03.045
sha: 06cb4fa91aee709fabbe2c44209f7c53f7f26a94
doc_id: 872486
cord_uid: u4y7d7de

INTRODUCTION Coronavirus disease 2019 (COVID-19) has spread worldwide and has become a public health emergency and a pandemic of international concern. The solid organ donation system was no different. This study aimed to investigate the effect of COVID-19 on the liver transplants (LT) system in Brazilian territory. MATERIAL AND METHODS We retrospectively reviewed all liver donor records allocated in São Paulo State, Brazil, 1 year before and 1 year during the COVID-19 pandemic. We defined the pre-COVID-19 period (PRE) between April 2019 to April 2020 and the post-COVID-19 period (POST) between April 2020 to April 2021. Moreover, we compared LT performed in our institution during these two periods. To evaluate outcomes, we compared 30-days survival after LT. RESULTS In Era PRE, 1452 liver donors were offered in São Paulo State and other Brazilian territories. These 592 were utilized in LT. In Era POST, 1314 liver donors were offered, but just 477 were utilized in LT. Organ refusal was higher in Era POST (p<0.05). Our center performed 127 and 156 liver transplants in these periods, respectively, an increase above 20% was significant (p=0.039). There was no difference in 30-days survival between the periods (87.2% vs. 87.9%, p>0,5, respectively). CONCLUSION The COVID19 pandemic harmed potential and allocated donors and liver transplants performed. However, it is possible to maintain the LT volume of a transplant center without compromising survival outcomes through preventive strategies against COVID-19 propagation.

Coronavirus disease 2019 (COVID-19) is caused by a novel coronavirus termed severe acute respiratory syndrome (1, 2) . The disease has spread worldwide and has become a public health emergency pandemic of international concern (3). Transplant programs worldwide were jeopardized by COVID-19, dwindling numbers of solid organs transplantations. The transplant society's recommendations and guidelines during the COVID-19 pandemic consider liver transplantation (LT) as safe procedure.

However, there is a lack of data about the impact of comorbidities, elapsed time since the organ transplant, immunosuppressive regimen, and vaccination on COVID-19 in LT patients. Therefore, the impact of pandemia in liver recipients remains largely unknown, as most data are derived from case reports and small retrospective series (4-6).

Sao Paulo is Brazil's most populous state and was the epicenter of the disease in the country. Our institution is one of the largest transplantation centers in Latin America, having performed more than 3000 liver transplants (LT), with an average of 160 LT per year (7) . This study aimed to investigate the effect of COVID-19 on the liver transplants system in this Brazilian territory.

We retrospectively reviewed all liver donor records allocated in São Paulo State, Brazil, 1 year before and 1 year during the COVID-19 pandemic. These records were available by Organ Procurement Organization (OPO). We defined the pre-COVID-19 period (PRE) between April 2019 to April 2020 and the post-COVID-19 period (POST) between April 2020 to April 2021. We enrolled potential donors and allocated donors compared with LT performed.

Moreover, we compared LT performed in our institution (Hospital das Clinicas da Universidade de Sao Paulo) during these two periods. In order to evaluate outcomes, we compared 30-days survival after LT.

Qualitative data are presented as absolute frequency and percentage. Categorical variables were analyzed using chi-square or exact Fisher tests. Groups of quantitative data were first analyzed about normality and homogeneity assumptions and then compared using t tests, one-way ANOVA, or nonparametric Kruskal-Wallis test accordingly. All tests were performed using Graph Prism version 9

(GraphPad Software, Inc, San Diego, CA, USA), with a=0.05 and a 95% confidence interval.

In Era PRE, 1.452 liver donors were offered for Sao Paulo State. There were 685 procurement organs, and 592 were utilized in liver transplants. In Era POST, 1.314 liver donors were offered for Sao Paulo State. There were 569 procurement organs, and these 477 were utilized in liver transplants, as demonstrated in Figure 1a . Organ refusal was significantly higher in Era POST (p<0.05).

Our center performed 127 and 156 liver transplants in these periods, respectively, an increase above 20% was comparatively significantly higher than the potential donor's liver (p=0.039). There was no difference in 30-days survival between the periods (87.2% vs. 87.9%, p>0.5, respectively), as demonstrated in Figure 1 (b) .

The COVID-19 pandemic has strongly affected many lives worldwide and the transplant community, including transplant recipients who urgently need transplantation. Since the pandemic started, intensive care unit beds have been scarce, thus reducing the odds of procuring transplantable solid organs from suitable donors. Our study shows that during the one year of the COVID-19 outbreak, there was an important reduction of potential liver donors compared to the same period in 2019 in some Brazilian territories.

Transplantation is the standard therapy for several end-stage diseases. Still, during the COVID-19 spread, the lower number of potential donors and intensive care unit's bed availability limited access to this treatment. Our study observed a more severe reduction in organ donations than in the previous period (8) .

Despite the reduction in the number of donors made available by the OPOs, our center increased the number of LT during the pandemic compared to the same period before the pandemic. Possible explanations may be related to strategies adopted to keep the program running, avoiding the impact on mortality in the list (9) . Another factor associated with the increase in the number of LT may be related to cases when a city-wide quarantine was declared on March 2020. To maintain LT activity, a building was specifically designated to non-COVID-19 patients. Moreover, we developed rapid screening protocols for donors and recipients, including clinical evaluation, chest computed tomography scans and real-time polymerase chain-reaction (RT-PCR) for SARS-CoV-2 from respiratory secretions (9) . Additionally, patients on the waiting list were fully informed about the risks of transplantation during the pandemic and we emphasized the importance of self-isolation afterwards.

Aside from the limited donor numbers, a potential donor-related COVID-19 transmission could have been a risk for transplanted patients; thus, extensive COVID-19 testing of donors has been considered mandatory from the beginning (9). We surveyed patients transplanted between March 24 and July 1 2020 (10) and found that seven patients developed COVID-19 in the early posttransplant period (ranging from 9 to 39 days). All these patients were transplanted from different donors, and no other recipients transplanted with an organ from these seven donors developed the infection. Furthermore, we found a significantly lower incidence of COVID-19 related diseases in transplanted recipients previously and/or waiting list patients were included (11) . In line with a previous paper (12) , those data may support the hypothesis that the COVID-19 transmission should not be considered donor-related, and the extensive testing procedure guarantees safe transplantation.

The COVID19 pandemic decreased available donors, but our Institution increased the number of LT without compromising survival outcomes following a strict protocol of preventive strategies against COVID-19 propagation.

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis

WHO Characterizes COVID-19 as A Pandemic

COVID-19 in solid organ transplantation patients: A systematic review

COVID-19 in solid organ transplant recipients: Initial report from the US epicenter

Earliest cases of coronavirus disease 2019 (COVID-19) identified in solid organ transplant recipients in the United States

Liver transplant recipients infected with SARS-CoV-2 in the early postoperative period: Lessons from a single center in the epicenter of the pandemic

The COVID-19 outbreak in Italy: Initial implications for organ transplantation programs

Enabling liver transplantation during the COVID-19 era: More than screening donors and recipients for SARS-CoV-2

Coronavirus Disease 2019 in the Early Postoperative Period of Liver Transplantation: Is the Outcome Really So Positive? Liver Transpl, 2021

COVID-19 in solid organ transplantation patients: A systematic review

How to guarantee liver transplantation in the north of Italy during the COVID-19 pandemic: A sound transplant protection strategy

Figure 1. The proportion between potential and allocated donors, liver transplants performed and LT in HCFMUSP (a) and 30-days survival in our center (b) in PRE-and